Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
The Journal of Molecular Diagnostics : JMD|January 27, 2006
Association of clinical status of follicular lymphoma patients after autologous stem cell transplant and quantitative assessment of lymphoma in blood and bone marrow as measured by SYBR Green I polymerase chain reactionNancy Pennell, Anthony Woods, Marciano Reis, et al.Cancer Immunology, Immunotherapy : CII|November 24, 2011
A short course of neoadjuvant IRX-2 induces changes in peripheral blood lymphocyte subsets of patients with head and neck squamous cell carcinomaTheresa L Whiteside, Lisa H Butterfield, Paul H Naylor, et al.Cancer|January 13, 2006
Enhanced viral and tumor immunity with intranodal injection of canary pox viruses expressing the melanoma antigen, gp100David E Spaner, Igor Astsaturov, Thorsten Vogel, et al.International Journal of Cancer|May 15, 2018
Serum-derived carcinoembryonic antigen (CEA) activates fibroblasts to induce a local re-modeling of the extracellular matrix that favors the engraftment of CEA-expressing tumor cellsAws Abdul-Wahid, Marzena Cydzik, Nicholas W Fischer, et al.Ejhaem|January 27, 2025
Characteristics of relapsed/refractory diffuse large B-cell lymphoma patients with durable responses to maveropepimut-S, pembrolizumab, and cyclophosphamide: Long-term follow-up from the SPiReL trialArjun Pandey, Kim Roos, Yidi Jiang, et al.European Journal of Haematology|May 9, 2023
PD-L1 expression predicts efficacy in the phase II SPiReL trial with MVP-S, pembrolizumab, and low-dose CPA in R/R DLBCLIrina Amitai, Kim Roos, Iran Rashedi, et al.Leukemia & Lymphoma|September 27, 2024
Intensity of survivin expression linked to features of aggressive relapsed/refractory diffuse large B-cell lymphomaSila Usta, Alexandra Misura, Iran Rashedi, et al.Hematological Oncology|May 1, 2018
Management of newly diagnosed high-risk and intermediate-risk follicular lymphoma with 90 Y ibritumomab tiuxetan in a phase II studyNeil L Berinstein, Nancy M Pennell, Rashmi Weerasinghe, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2007
Characterization of antigen-specific immune responses induced by canarypox virus vaccinesRinke Bos, Suzanne van Duikeren, Thorbald van Hall, et al.Journal of Translational Medicine|August 7, 2012
First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patientsNeil L Berinstein, Mohan Karkada, Michael A Morse, et al.Pageof 4